Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer
Clinical trial NCT03475004 · COMPLETED
Trial details
- NCT number
- NCT03475004
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-17
- Primary completion
- 2022-04-14
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.